- Release Date: 30/03/20 08:28
- Summary: Opthea Completes Patient Dosing in Phase 2a DME Trial
- Price Sensitive: Yes
- Download Document 174.45KB
Ann: Opthea Completes Patient Dosing in Phase 2a DME Trial
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.5¢ |
Change
0.025(6.10%) |
Mkt cap ! $529.3M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 44.0¢ | 42.0¢ | $481.4K | 1.131M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 39958 | 43.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.5¢ | 58886 | 7 |
View Market Depth
| Last trade - 13.44pm 29/07/2024 (20 minute delay) ? |
| OPT (ASX) Chart |